Application 089365
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VINBLASTINE SULFATE | VINBLASTINE SULFATE | Injectable; Injection | 10MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vinblastine Sulfate | VINBLASTINE SULFATE | Fresenius Kabi USA, LLC | f073b58e-56d6-4c8d-a2ce-b37719402d77 | 2025-04-15 | Boxed warning, Warnings, Adverse reactions | Vinblastine Sulfate VINBLASTINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.